WealthTrust Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,479
Closed -$1.92M 79
2022
Q4
$1.92M Buy
37,479
+15,028
+67% +$720K 1.86% 14
2022
Q3
$982K Buy
+22,451
New +$1.09M 1.04% 29

Other funds holding PFE

WealthTrust Asset Management's PFE Position: Q1 2023 in Review

WealthTrust Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 37,479 shares — an estimated $1.92M sold.

WealthTrust Asset Management first reported a position in PFE in Q3 2022 and held it in 2 quarters. The position peaked at $1.92M in Q4 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • WealthTrust Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • WealthTrust Asset Management sold 37,479 Pfizer shares in Q1 2023, an estimated $1.92M.
  • WealthTrust Asset Management first reported a position in Pfizer in Q3 2022 and held it in 2 quarters.
  • WealthTrust Asset Management's Pfizer position peaked at $1.92M in Q4 2022.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on WealthTrust Asset Management's 13F filing for Q1 2023, filed 28 Apr 2023.